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DObjective: Selected patients appear to benefit from off-pump coronary artery bypass compared with conven-
tional coronary artery bypass with cardiopulmonary bypass. It is unknown whether elderly patients undergoing
isolated coronary artery bypass grafting operations derive any benefit when performed off-pump. We hypothe-
sized that off-pump coronary bypass offers a greater operative benefit to elderly patients when compared with
conventional coronary artery bypass.
Methods:A total of 1993 elderly patients (age 80years) underwent isolated, primary coronary artery bypass graft
operations at 16 different statewide centers from 2003 to 2008. Patients were stratified into 2 groups: conven-
tional coronary artery bypass (n ¼ 1589, age ¼ 82.5  2.4 years) and off-pump bypass (n ¼ 404, age ¼ 83.0 
2.4 years). Preoperative risk, intraoperative findings, postoperative complications, and costs were evaluated.
Results: Patients undergoing off-pump bypass grafting were marginally older (P¼ .001) and had higher rates of
preoperative atrial fibrillation (14.6% vs 10.0%; P¼ .01) and NewYork Heart Association class IV heart failure
(29.7% vs 21.1%; P<.001) than did those having conventional coronary bypass grafting. Other patient risk
factors and operative variables, including Society of Thoracic Surgeons predicted risk of mortality, were similar
in both groups (P¼ .15). Compared with off-pump bypass, conventional coronary bypass incurred higher blood
transfusion rates (2.0  1.7 units vs 1.6  1.9 units; P ¼ .05) as well as more postoperative atrial fibrillation
(28.4% vs 21.5%; P ¼ .003), prolonged ventilation (14.7% vs 11.4%; P ¼ .05), and major complications
(20.1% vs 15.6%; P ¼ .04). Importantly, postoperative stroke (2.6% vs 1.7%; P ¼ .21), renal failure (8.1%
vs 6.2%; P ¼ .12), and postoperative length of stay (P ¼ .41) were no different between groups. Despite
more complications in patients having conventional bypass, operative mortality (P ¼ .53) and hospital costs
(P ¼ .43) were similar to those of patients having off-pump procedures.
Conclusions: Performance of coronary artery bypass grafting among octogenarian patients is safe and effective.
Off-pump coronary artery bypass confers shorter postoperative ventilation but equivalent mortality to conven-
tional coronary artery bypass. Off-pump coronary artery bypass was associated with a reduction in the composite
incidence of major complications in unadjusted and adjusted analyses and should be considered an acceptable
alternative to conventional bypass for myocardial revascularization in elderly patients. (J Thorac Cardiovasc
Surg 2011;141:81-90)The increasing performance of off-pump coronary artery
bypass grafting (OPCAB) within certain centers reflects
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The Journal of Thoracic and Cmonary bypass (CPB) and cardioplegic arrest including he-
modilution, nonpulsatile arterial flow, global myocardial
ischemia, atherosclerotic embolization from aortic manipu-
lation, and systemic inflammatory response. According to
the Society of Thoracic Surgeons (STS) National Adult
Cardiac Surgery Database, more than 163,000 isolated cor-
onary artery bypass grafting operations were performed in
2009, of which OPCAB accounted for just over 34,000
(20.8%).1 These trends reflect a variety of motivators, in-
cluding surgeon and patient preference, patient risk, and
the perceived benefits of OPCAB compared with conven-
tional coronary artery bypass grafting with CPB (CABG).
Selected groups of patients appear to benefit from
OPCAB compared with conventional CABG. In a large
observational study, OPCAB has been shown to benefit pa-
tients requiring high-risk cardiac surgery (STS predicted
risk of mortality> 2.5%) over conventional CABG.2 In
addition, patients with an acute ST-elevation myocardial in-
farction, patients with renal insufficiency, those withardiovascular Surgery c Volume 141, Number 1 81
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting with
cardiopulmonary bypass
CPB ¼ cardiopulmonary bypass
ITA ¼ internal thoracic artery
NYHA ¼ New York Heart Association
OPCAB ¼ off-pump coronary artery bypass
grafting
PRBC ¼ packed red blood cell
PROM ¼ predicted risk of mortality
STS ¼ Society of Thoracic Surgeons
VCSQI ¼ Virginia Cardiac Surgery Quality
Initiative
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Dcerebrovascular disease, and women appear to have better
outcomes with OPCAB than with conventional CABG.
With a rising elderly cardiac surgical population,3 outcomes
in patients with advanced age need critical evaluation. Sev-
eral series have documented cardiac surgical outcomes
among elderly patients with varying results.3-6 It is
unknown whether elderly patients undergoing isolated
CABG operations derive any benefit when performed off-
pump.
The objective of this study was to examine the effect of
performing OPCAB within octogenarians. We hypothe-
sized that OPCAB offers a greater operative benefit to
elderly patients with respect to operative risk, postoperative
morbidity, and total costs than does conventional CABG.PATIENTS AND METHODS
Patients
Owing to the absence of patient identifiers within the Virginia Cardiac
Surgery Quality Initiative (VCSQI) database and the fact that the data are
collected for purposes other than research, data analyses were exempt
from the University of Virginia Institutional Review Board. In addition,
participating institutions were exempt from Health Insurance Portability
and Accountability Act consideration by the use of the Small Business
Agreement for Business Associates agreements between each hospital
and participating surgeons. The VCSQI is a voluntary consortium of 16
different cardiac surgical centers and hospitals within the Commonwealth
of Virginia that, collectively, captures approximately 99% of Virginia’s
cardiac surgical procedures. All CABG operations were entered prospec-
tively into the National STS Adult Cardiac Surgery Database by partici-
pating VCSQI centers. Long-term follow-up beyond 30 days, like the
STS Database, is not collected in the VCSQI. We retrospectively reviewed
all patients undergoing primary, isolated coronary artery bypass grafting
operations as reported by the VCSQI from January 2003 to December
2008. Primary operations were those occurring in the absence of a prior
sternotomy or cardiac operation. Patients were stratified into 2 study
groups according to the use of CPB: conventional coronary artery bypass
grafting with CPB (CABG) and off-pump coronary artery bypass grafting
(OPCAB).
Patient risk factors, operative features, postoperative outcomes, and to-
tal hospital costs were evaluated. We used established STS definitions for
all patient variables and postoperative outcomes.7 Operative mortality in-82 The Journal of Thoracic and Cardiovascular Surgecluded in-hospital death during the same admission or within 30 days of
operation. Major complications included the composite incidence of
postoperative stroke, renal failure, prolonged ventilation, pneumonia, and
myocardial infarction. Total hospital costs were estimated calculations as
reported by the VCSQI.
Statistical Analysis
All outcomes analyzed in this study were established a priori to reduce
the potential for type I error. The primary outcomes of interest were
operative mortality and major complication rate, and secondary outcomes
included postoperative length of stay and total costs. All group compari-
sons were unpaired. Continuous variables were compared using analysis
of variance, and categorical variables were compared using c2 analysis
or Fisher’s exact tests as appropriate.
Multivariable logistic regression was performed to assess the indepen-
dent effects of known preoperative risk factors on the odds of operative
mortality and postoperative complication rates between both CABG and
OPCAB groups. All preoperative variables entered as covariates (age,
sex, preoperative renal failure, stroke, atrial fibrillation, New York Heart
Association [NYHA] class, elective operative status, ejection fraction,
left main coronary occlusion> 50%, intraoperative packed red blood
cell [PRBC] transfusion, and performance of OPCAB) were selected a pri-
ori on the basis of established clinical risk during CABG operations before
data analysis. The estimated odds of morbidity and mortality were adjusted
for all covariates. The discrimination achieved by these models was as-
sessed using the area under the receiver operating characteristics curve.
Values of 1.0 for the area under the receiver operating characteristics curve
indicate perfect discrimination between outcome groups, whereas values of
0.5 indicate results equal to chance. Model calibration across deciles of ob-
served and predicted risk was assessed using the Hosmer–Lemeshow test.
Categorical variable comparisons are expressed as a percentage of the
group of origin. Continuous variables are reported as means standard de-
viation. Odds ratios with a 95% confidence interval are used to report the
results of logistic regression models. Reported P values are 2-tailed. Data
manipulation and analysis were performed with SPSS software, version 17
(SPSS, Inc, Chicago, Ill).RESULTS
Patient Risk Factors and Operative Features
A total of 1993 octogenarian (80 years old) patients un-
derwent primary, isolated coronary artery bypass grafting
operations in Virginia during the 6-year study period:
CABG (n ¼ 1589) and OPCAB (n ¼ 404). All patient
demographics, preoperative risk factors, and operative fea-
tures are presented in Table 1. Study cohorts were well
matched with respect to patient comorbid disease and pre-
operative risk. Average STS predicted risk of mortality
(PROM) was 5.7%  7.1% for patients having conven-
tional CABG and 6.3%  6.9% for those having OPCAB
(P¼ .15), and the incidence of left main coronary artery oc-
clusion of 50% or more was similar between groups. OP-
CAB patients were marginally older than CABG patients
with higher incidence of preoperative stroke, NYHA class
IV functional status, and atrial fibrillation. CABG patients
had a higher incidence of 3-vessel or greater coronary dis-
ease. Overall, internal thoracic artery (ITA) use was more
common among OPCAB operations (P < .001), and
OPCAB (89.4% vs 81.4%; P<.001) patients underwent
a higher percentage of left ITA anastomoses. A higherry c January 2011
TABLE 1. Patient demographics, preoperative risk factors, and
operative features for all patients undergoing primary, isolated
coronary artery bypass grafting operations
Variable
CABG
(n ¼ 1589)
OPCAB
(n ¼ 404) P value
Preoperative
Age at operation (y) 82.5  2.4 83.0  2.4 <.001
Female gender 38.6% 42.1% .11
Peripheral vascular disease 18.9% 19.6% .40
Stroke 8.3% 11.6% .03
Diabetes 30.5% 27.2% .11
Dyslipidemia 73.4% 60.9% <.001
Hypertension 83.9% 81.2% .11
NYHA class
Class I 13.2% 6.2% <.001
Class II 22.3% 22.0%
Class III 43.5% 42.1%
Class IV 21.1% 29.7%
Heart failure 13.5% 18.9% .20
Atrial fibrillation 10.0% 14.6% .01
Endocarditis 0.0% 0.0% N/A
Renal failure 5.8% 7.4% .14
Renal failure
(hemodialysis)
1.0% 1.5% .28
No. of major arteries with stenosis>50%
1 2.1% 16.2% <.001
2 13.9% 30.2%
3 84.0% 53.6%
Left main stenosis>50% 38.6% 36.9% .53
STS PROM (%) 5.7  7.1 6.3  6.9% .15
Operative
Elective 38.3% 40.3% .87
Urgent 57.3% 54.7%
Emergency 4.3% 5.0%
Crossclamp time (min) 63.9  23.8 — —
Bypass time (min) 92.2  34.0 — —
Total no. of bypass grafts 3.4  0.02 2.2  0.07 <.001
Overall ITA use 82.3% 91.9% <.001
LITA 81.4% 89.4%
RITA 0.3% 0.0%
Bilateral ITA 0.4% 2.1%
Distal arterial anastomosis (no.)
1 75.7% 84.6% .01
2 4.6% 6.0%
3 1.2% 0.9%
>4 0.6% 0.4%
Distal vein anastomosis (no.)
0 3.2% 31.1% <.001
1 10.6% 28.2%
2 39.5% 29.1%
3 33.9% 10.7%
>4 12.8% 0.9%
(Continued)
TABLE 1. Continued
Variable
CABG
(n ¼ 1589)
OPCAB
(n ¼ 404) P value
Radial artery anastomosis (no.)
1 4.1% 4.0% .14
2 4.1% 0.0%
3 1.2% 0.0%
PRBC transfusion (units) 2.0  1.7 1.6  1.0 .05
CABG, Conventional coronary artery bypass grafting; OPCAB, off-pump coronary
artery bypass grafting; NYHA,NewYork Heart Association; STS, Society of Thoracic
Surgery; PROM, predicted risk of mortality ITA, internal thoracic artery; LITA, left
internal thoracic artery; RITA, right internal thoracic artery; PRBC, packed red blood
cell; N/A, not applicable.
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Dnumber of total grafts (P¼ .001) were used in CABG oper-
ations than in OPCAB. OPCAB operations included
a higher frequency of arterial anastomoses (P ¼ .01),The Journal of Thoracic and Cwhereas CABG operations included more vein graft anasto-
moses (P<.001). Importantly, operative status (elective, ur-
gent, emergency) was similar between study groups.Unadjusted Outcomes for Conventional CABG and
OPCAB
Postoperative outcomes for octogenarian patients under-
going conventional CABG and OPCAB operations are pre-
sented in Table 2. Patients undergoing conventional CABG
accrued higher intraoperative transfusion requirements.
Compared with OPCAB, conventional CABG incurred
more postoperative atrial fibrillation (28.4% vs 21.5%;
P ¼ .003), prolonged ventilation (14.7% vs 11.4%;
P¼ .05), and major complications (P¼ .04) (Figure 1). Im-
portantly, postoperative stroke (2.6% vs 1.7%; P ¼ .21)
and renal failure (8.1% vs 6.2%; P¼ .12) rates were no dif-
ferent between groups. Despite more complications in
CABG patients, operative mortality was similar after both
CABG (5.1%) and OPCAB (5.9%; P ¼.53) operations.
Moreover, patients had similar total hospital (P ¼ .75)
and postoperative (P¼ .41) lengths of stay as well as similar
total costs (P ¼ .43).Factors Related to Mortality in Patients Undergoing
Conventional CABG and OPCAB
Univariate analyses of all preoperative and operative risk
factors are listed for all survivors and decedents after both
conventional CABG and OPCAB operations in Table 3.
Among conventional CABG operations, mortality was
more frequent in women, those with NYHA class IV status,
heart failure, lower ejection fraction, and preoperative atrial
fibrillation. Decedents expectedly had higher STS PROM
and underwent a higher percentage of nonelective opera-
tions with longer CPB times.
Among OPCAB patients, decedents more commonly had
higher NYHA class, preoperative hemodialysis require-
ments, higher STS PROM, and underwent more emergency
operations than did survivors. In contrast to those undergo-
ing conventional CABG, female gender was not associatedardiovascular Surgery c Volume 141, Number 1 83
TABLE 2. Unadjusted postoperative outcomes for all patients
undergoing primary, isolated coronary artery bypass grafting
operations
Outcome
CABG
(n ¼ 1589)
OPCAB
(n ¼ 404)
P
value
Sepsis 1.4% 0.7% .22
Stroke 2.6% 1.7% .21
Myocardial infarction 0.3% 1.2% .03
Cardiac arrest 2.6% 1.7% .21
Reoperation for graft
occlusion
0.1% 0.0% .64
Atrial fibrillation 28.4% 21.5% .003
Gastrointestinal event 3.3% 3.2% .55
Pneumonia 5.0% 5.0% .55
Prolonged ventilation 14.7% 11.4% .05
Renal failure 8.1% 6.2% .12
Hemodialysis 3.1% 2.5% .30
ICU LOS (h) 101.3  173.0 84.8  110.8 .21
Postoperative LOS (d) 9.04  10.0 9.52  10.5 .41
Hospital LOS (d) 12.39  11.1 12.20  10.6 .75
Major complication 20.1% 15.6% .04
Operative mortality 5.1% 5.9% .53
Readmission
<30 days
9.7% 10.6% .31
ICU/CCU cost ($) 8,826.70  11,564.90 7,645.16  7,845.56 .08
Total cost ($) 36,755.18 
34,650.30
35,030.55 
34,634.70
.43
Boldface indicates statistically significant P values. CABG, Conventional coronary
artery bypass grafting; OPCAB, off-pump coronary artery bypass grafting; ICU,
intensive care unit; LOS, length of stay; CCU, cardiac care unit.
FIGURE 1. Incidence of postoperative outcomes contributing to compos-
ite incidence of major complications for patients undergoing primary, iso-
lated CABG or OPCAB operations. MI, Myocardial infarction; CABG,
conventional coronary artery bypass grafting; OPCAB, off-pump coronary
artery bypass grafting.
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univariate analysis.
There were several different causes for mortality among
those undergoing coronary artery bypass grafting opera-
tions (Figure 2). Overall, the most common primary cause
of patient mortality was cardiac in origin (47.6%), followed
by pulmonary (17.1%) and neurologic (10.5%) etiologies.
Renal causes accounted for 5.7% of patient mortality
whereas infections were responsible for 4.8% of deaths.
Risk-Adjusted Mortality and Morbidity
Risk-adjusted odds ratios and multivariable logistic re-
gression results for operative mortality among all octoge-
narian patients undergoing coronary bypass operations are
displayed in Table 4. Operative mortality was associated
with female gender, preoperative atrial fibrillation, presence
of left main coronary artery occlusion of 50% or more, and
degree of intraoperative PRBC transfusion. An increase in
the odds of mortality was associated with performance of
urgent/emergency operations and depressed ventricular
function. Importantly, performance of OPCAB among octo-
genarians was not an independent predictor of operative
mortality (P ¼ .87).
Multivariable logistic regression revealed similar results
for risk-adjusted postoperative complication rates among84 The Journal of Thoracic and Cardiovascular Surgeoctogenarians (Table 4). Within the model for any postoper-
ative complication, patient age and preoperative renal fail-
ure independently increased the odds of a postoperative
complication. In contrast, urgent/emergency operative sta-
tus and depressed ventricular function increased the odds
of complications. Similar trends were observed for the
model constructed for the composite outcome ofmajor com-
plication rate. Importantly, performance of OPCAB was as-
sociated with decreased odds of any postoperative
complication (odds ratio¼ 0.74 [0.59–0.93];P¼ .01) orma-
jor complication (odds ratio ¼ 0.68 [0.50–0.93]; P ¼ .02)
compared with the performance of a conventional CABG.DISCUSSION
This study adds to the mounting body of evidence exam-
ining the comparative effectiveness of conventional on-
pump versus off-pump coronary revascularization among
select patient populations, and it highlights the short-term
morbidity benefits of OPCAB among octogenarian patients.
Within this large, multi-institutional patient cohort, OP-
CAB was performed in 20% of cases, which is similar to
nationwide trends. Operative mortality rates were compara-
ble between both conventional CABG (5.1%) and OPCAB
(5.9%; P ¼ .29) groups. We similarly demonstrated equiv-
alent intensive care unit and hospital lengths of stay as well
as total hospital costs for both study groups. Importantly, as
documented in other studies, we demonstrated reduced in-
traoperative transfusion requirements, lower postoperative
atrial fibrillation rates, decreased prolonged ventilation,
and lower major complication rates after OPCAB. More-
over, performance of OPCAB compared with CABG signif-
icantly decreased risk-adjusted postoperative complication
rates by 26% and major complication rates by 32% onmul-
tivariable logistic regression. These results corroborate ar-
guments for the safety and beneficial effects of OPCAB
compared with CPB use during surgical, myocardial revas-
cularization.ry c January 2011
TABLE 3. Univariate comparisons of patient and operation-related risk factors for survivors and decedents undergoing primary, isolated
coronary artery bypass grafting operations
CABG (n ¼ 1589) OPCAB (n ¼ 404)
Variable Survivors (n ¼ 1508) Decedents (n ¼ 81) P value Survivors (n ¼ 221) Decedents (n ¼ 13) P value
Preoperative
Age at operation (y) 82.5  0.07 82.6  0.14 .09 83.0  0.13 83.1  0.34 .27
Female gender 37.5% 59.3% <.001 41.8% 45.8% .83
Peripheral vascular disease 18.5% 25.9% .11 18.7% 33.3% .11
Stroke 8.5% 4.9% .41 11.6% 12.5% .75
Diabetes 30.1% 37.0% .22 27.1% 29.2% .82
Dyslipidemia 73.3% 75.3% .79 60.3% 70.8% .39
Hypertension 83.6% 90.1% .16 80.8% 87.5% .59
NYHA class
Class I 13.2% 12.3% .39 6.3% 4.2% .04
Class II 22.5% 18.5% 23.2% 4.2%
Class III 43.8% 37.0% 42.6% 33.3%
Class IV 20.5% 32.1% 27.9% 58.3%
Heart failure 16.2% 29.6% .003 18.7% 21.7% .78
Atrial fibrillation 9.2% 24.7% <.001 14.5% 16.7% .77
Endocarditis 0.0% 0.0% N/A 0.0% 0.0% N/A
Renal failure 5.4% 12.3% .02 7.4% 8.3% .70
Hemodialysis 1.0% 1.2% .57 1.1% 8.3% .04
Ejection fraction (%) 51.1  12.7 45.8  15.4 <.001 51.4  12.4 48.4  11.1 .27
STS PROM (%) 5.16  4.89 15.82  20.8 <.001 5.80  6.21 14.0  11.7 <.001
Operative
Elective 39.3% 21.0% <.001 41.6% 20.8% .001
Urgent 57.2% 58.0% 54.5% 58.3%
Emergency 3.4% 21.0% 3.9% 20.8%
Crossclamp time (min) 63.8  23.6 64.7  27.7 .74 N/A N/A N/A
Bypass time (min) 91.5  33.4 104.9  41.8 <.001 N/A N/A N/A
PRBC transfusion (units) 1.97  0.03 2.46  0.17 .16 1.93  0.02 1.94  1.0 .16
Boldface indicates statistically significant P values. CABG, Conventional coronary artery bypass grafting; OPCAB, off-pump coronary artery bypass grafting; NYHA, New York
Heart Association; STS, Society of Thoracic Surgeons; PROM, predicted risk of mortality; PRBC, packed red blood cell; N/A, not available.
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tients has been increasingly emphasized in recent literature.
Several series have reported longer hospital stays as well
as increased morbidity and mortality among octogenarian
patients after cardiac operations.8-10 Worse survival seen
among octogenarians has been attributed to the higher
prevalence of complex comorbid disease in elderly
patients.8-10 Further, increasing evidence suggests that
a combination of intraoperative factors, including CPB
time, transfusion requirements, and left ITA
revascularization, are important determinants of survival
among octogenarians undergoing coronary artery bypass
grafting, contributing to an 8% to 12% operative mortality
rate among these patients.9,11,12 In this series, the 5.3%
overall mortality rate and relatively low incidence of
postoperative complications compare favorably and may
be due to factors related to patient selection. In addition,
our results suggest that overall outcomes after coronary
artery bypass grafting operations within octogenarians
have improved in recent times and that surgical myocardial
revascularization can be performed safely and with
acceptable operative risk.The Journal of Thoracic and COver the past few decades, resurgence in the popularity of
OPCAB has occurred throughout North and South America,
and comparisons documenting the potential benefits and pit-
falls of CPB use have varied. Several randomized controlled
trials have been performed to assess outcomes for OPCAB
compared with CABG with mixed results. In the Octopus
trial, no significant differences in perioperative morbidity
ormortalitywere reported forCABGversusOPCAB in a co-
hort of 281 patients, but reductions in duration of mechani-
cal ventilation and hospital stay were noted.13 Similarly,
Puskas and colleagues14 demonstrated equivalent in-
hospital and 30-day outcomes for OPCAB as well as similar
complete revascularization rates, shorter lengths of say, re-
duced transfusion requirements, and less myocardial injury.
Recently, Angelini and colleagues15 reported long-term re-
sults for 2 randomized controlled trials, demonstrating
equivalent long-term (6–8 years) outcomes despite the use
of CPB among experienced OPCAB surgeons. These results
are in direct contrast to those reported in the recent random-
ized on/off bypass (ROOBY) trial, which demonstrated
equivalent short-term (30-day) outcomes for CABG and
OPCAB operations, but reported worse long-term (1 year)ardiovascular Surgery c Volume 141, Number 1 85
FIGURE 2. Incidence of primary cause of mortality for decedents after isolated CABG or OPCAB operations.CABG,Conventional coronary artery bypass
grafting; OPCAB, off-pump coronary artery bypass grafting.
Acquired Cardiovascular Disease LaPar et al
A
C
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and graft patency for OPCAB.16 Similarly, a recent
meta-analysis also suggested worse long-term graft patency
rates among OPCAB operations.17 Alternatively, several
meta-analyses and large observational studies have reported
equivalent and, in some cases, improved surgical outcomes
for the performance of OPCAB over conventional
CABG.18-22 The variance in reported outcomes within
available literature highlights the unsettled debate
regarding the success of OPCAB versus CABG. However,
the majority of series lacks a significant population of
octogenarian patients and includes a relatively low-risk
patient cohort. More important, a lack of evidence exists ex-
amining the effect of OPCAB within the octogenarian pop-
ulation, and the question of the importance of long-term
graft patency within the extreme elderly remains
unanswered.
Efforts to identify which surgical populations may bene-
fit from OPCAB over conventional CABG are increasing.TABLE 4. Risk-adjusted odds ratios for the effect of selected preoperative a
mortality, any postoperative complication, and major complication rate in e
Preoperative or operative
risk factor Operative mortality
Patient age 1.06 (0.98–1.14)
Female gender 2.44 (1.60–3.72)*
Renal failure 1.82 (0.91–3.62)
Stroke 0.70 (0.32–1.56)
Atrial fibrillation 2.10 (1.26–3.51)*
NYHA class III 0.87 (0.52–1.48)
NYHA class IV 1.37 (0.79–240)
Urgent/emergency operation 1.43 (1.04–1.66)*
Ejection fraction 0.98 (0.96–0.99)*
Left main disease>50% 1.60 (1.06–2.42)*
OPCAB 1.04 (0.63–1.71)
PRBC transfusion (units) 1.22 (1.03–1.44)*
NYHA, New York Heart Association; OBCAB, off-pump coronary artery bypass grafting; P
confidence interval). All model covariates selected a priori based on established clinical r
86 The Journal of Thoracic and Cardiovascular SurgeIn a large, single-institutional review of more than 11,000
isolated CABG operations, Puskas and colleagues23
demonstrated disproportionately improved outcomes for
women undergoing OPCAB compared with CABG. Specif-
ically, in this review, women undergoing CABG had 60%
increased odds of death, 71% increased odds of stroke,
and 71% increased odds for major adverse cardiac events
compared with men undergoing CABG; however, this in-
creased risk for women was negated in women undergoing
OPCAB. In another recent series, this same group demon-
strated that OPCAB has greatest benefits for high-risk
patients, based on STS PROM.2 Their analysis of 14,766
primary, isolated CABG operations over a 10-year period
revealed that patients with PROM values greater than
2.5% derived a significant mortality benefit when undergo-
ing OPCAB compared with CABG. In this study, average
patient age was approximately 62 years, and only 38% of
all patients were older than 66 years. As a result, these stud-
ies fail to completely demonstrate any advantage ofnd operation-related patient risk factors for the outcomes of operative
lderly patients undergoing coronary artery bypass grafting operations
Any complication Major complications
1.05 (1.01–1.09)* 1.02 (0.97–1.06)
0.94 (0.78–1.14) 1.22 (1.13–1.84)*
1.47 (0.99–2.19) 2.19 (1.43–3.36)*
1.16 (0.85–1.60) 1.27 (0.86–1.88)
0.80 (0.60–1.07) 1.36 (0.96–1.92)
1.07 (0.86–1.33) 1.06 (0.79–1.42)
1.29 (0.99–1.69) 1.66 (1.20–2.31)
1.19 (1.01–1.34)* 1.35 (1.14–1.50)*
0.99 (0.98–0.99)* 0.98 (0.98–0.99)*
1.13 (0.94–1.37) 1.49 (1.17–1.89)*
0.74 (0.59–0.93)* 0.68 (0.50–0.93)*
0.99 (0.89–1.09) 1.16 (1.02–1.32)*
RBC, packed red blood cell. *P<.05. Results reported as adjusted odds ratios (95%
isk before data analyses.
ry c January 2011
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the documented improvements of OPCAB are not only in
agreement with the findings of these 2 previous studies,
but further highlight an apparent morbidity benefit of OP-
CAB for patients older than 80 years of age. Similar to Pus-
kas and associates,23 we found that female gender among
elderly patients was significantly associated with mortality
after CABG operations; however, this disparity disappeared
after OPCAB. This association was determined by univari-
ate analyses and was not a product of a statistical interaction
on multivariate regression analysis. As a result, this study
identifies OPCAB as a safe alternative to CABG in octoge-
narians and suggests that elderly woman may derive the
most benefit from OPCAB. Importantly, however, our re-
sults do not suggest that OPCAB provides any additional
benefit to elderly patients with preoperative stroke or renal
failure.
Several potential explanations exist for our observed re-
sults. The performance of conventional CABG in the pres-
ent study may be due to a surgeon selection bias of more
complex patients and could explain the higher morbidity
we observed in this group compared with those undergoing
OPCAB. Unfortunately, we were unable to account for such
selection bias in this retrospective, statewide review. It is,
however, important to note that STS PROM was similar be-
tween groups with a trend toward a higher risk in OPCAB
patients. The influence of prolonged ventilation on the com-
posite incidence of major complications may reflect indi-
vidual surgeon preference to avoid accelerated extubation
in elderly patients or actual detriments of CPB on pulmo-
nary function. In addition, higher transfusion requirements,
as seen in multiple other studies, within patients undergoing
conventional CABG may have contributed to the higher in-
cidence of prolonged mechanical ventilation in this group
as a result of acute lung injury. However, the inclusion of
PRBC transfusion requirements in our estimated models
likely controlled for the independent influence of this factor
on adjusted mortality and complication rates. The discrep-
ancy between the slightly higher morbidity in patients
undergoing conventional CABG, despite the similar mortal-
ity between groups, may represent the clinical effect of
transient, but recoverable, postoperative events on
outcomes that can occur during surgery.
Several noteworthy results of this study deserve further
discussion. First, higher postoperative myocardial infarction
rates were observed for octogenarian OPCAB patients. Un-
fortunately, owing to the de-identified nature of the VCSQI
data set, we were unable to more completely analyze the cir-
cumstances of these events. However, these observations are
consistent with previously reported inferior long-term graft
patency rates for OPCAB operations.16,17 However, the
effect of better long-term graft patency may or may not be
relevant in octogenarians, especially considering these stud-
ies do not demonstrate a survival benefit with conventionalThe Journal of Thoracic and CCABG. Second, higher ITA usewas observed inOPCABop-
erations in this series and is difficult to explain. Unfortu-
nately, the underlying reason for this observation remains
unclear. Lower rates of ITA use may occur in the emergency
setting; however, the incidence of emergency operations in
this study is similar between the 2 groups.
This study has several limitations to note. The retrospec-
tive nature of this study introduced the possibility of inher-
ent selection bias. Additionally, the influence of small,
unmeasured differences in patient risk factors between
CABG andOPCAB groupsmay account for some of the dif-
ferences in observed outcomes. Previously established STS
definitions for all outcomes and study variables limited our
ability to extrapolate results to a broader patient group.
Completely de-identified patient data did not allow us to
scrutinize certain data, including conversion rates between
OPCAB and conventional CABG cohorts, complete versus
incomplete myocardial revascularization rates, degree of as-
cending aortic calcification, or quality of target vessels. Fur-
ther, as higher PRBC transfusion rates were observed for
patients undergoing conventional CABG, we were unable
to determine individual institution transfusion protocols to
more completely analyze the influence of PRBC transfusion
on postoperative outcomes. In addition, our study lacks in-
termediate or long-term follow-up, and we were only able
to comment on short-term outcomes. The estimated cost in-
formation provided by the VCSQI was imperfect. Further-
more, the relatively low incidence of operative mortality
after CABG operations limited modeling efforts for ad-
justed outcomes and constrained our efforts for adjust for
the potential confounding influence of factors including
the number of diseased vessels. Finally, the potential influ-
ence of an unmeasured confounder may, in part, explain
some of the estimated effects observed between operative
groups during logistic regression modeling. Nevertheless,
the results of this study provide an important context from
which to base future prospective studies.CONCLUSIONS
In this study, we conclude that performance of coronary
artery bypass grafting among octogenarian patients is safe
and effective. Outcomes after both conventional CABG
and OPCAB are similar; however, surgical revasculariza-
tion without CPB confers shorter postoperative ventilation
requirements. OPCAB was associated with a reduction in
the composite incidence of major complications in unad-
justed and adjusted analyses and should be considered an
acceptable alternative to conventional CABG for myocar-
dial revascularization in elderly patients.
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Dr James I. Fann (Stanford, Calif). I compliment you on awon-
derful presentation and a very interesting paper. You and your col-
leagues are to be congratulated for taking on the challenge of
clarifying the outcomes of on-pump (conventional CABG) versus
off-pump (OPCAB) approach to coronary revascularization in an
elderly patient population of nearly 2000 octogenarians over
a recent 6-year period.
The distribution of patients undergoing OPCAB was similar to
the national average at approximately 20%. Given the retrospec-
tive nature of the analysis, the patients were remarkably similar ex-
cept for age, incidence of preoperative atrial fibrillation, stroke,
and the incidence of class IV functional class, all of which were
slightly to moderately higher in the OPCAB group. Your analysis
showed that despite more postoperative complications in the con-
ventional CABG group, the operative mortality rates and hospital
costs were similar between the groups. Your conclusion that OP-
CAB coronary revascularization should be considered as an ac-
ceptable alternative to the conventional CABG approach in
elderly patients seems to be reasonable, but there are some issues
that need to be clarified and may increase the impact regarding
previous and potentially future decision-making.
I will limit my questions to 3 main categories. First is the issue
of number of grafts. Forty-six percent or nearly half the patients in
the OPCAB group had 1- or 2-vessel disease compared with 16%
in the conventional CABG group. Stated another way, 84% of the
patients in the conventional CABG group had 3-vessel disease
compared with slightly over half (54%) in the OPCAB group.
Hence, the patient cohorts are different. The question is, how do
you think the number of needed grafts affected patient selection
and how would you compare this finding of fewer grafts in the
OPCAB group with what others have reported?
Dr LaPar. Thank you very much for those kind comments,
Dr Fann. As you identified, clearly there is a selection bias as
we concluded in patients who were being selected for OPCAB,
and the selection bias does clearly select out patients requiring
fewer numbers of grafts and having less multivessel disease. Our
data show that and are consistent with what has been reported else-
where in previous studies as well.
Dr Fann. Second, the incidence of postoperativemyocardial in-
farction was low overall, but this complication was significantly
higher in the OPCAB group at 1.2% compared with 0.3% in the
conventional CABG cohort. Although this higher incidence might
not have affected the overall mortality, it is of concern, and it is im-
portant to know the outcome of these 5 patients. For instance, what
was the extent of the myocardial infarction? What were the diag-
nostic criteria for the myocardial infarction? Were the grafts pat-
ent? Did any patient require reoperation, percutaneous
intervention, or intra-aortic balloon pump placement? How
many of these cases were fatal?
Dr LaPar. You are absolutely right. Although we did not pres-
ent it in this presentation, the perioperative myocardial infarctionry c January 2011
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significant. As you pointed out, 5 patients within the OPCAB
group, that is, 5 of 404 patients, did have postoperative myocardial
infarction. Unfortunately, owing to the de-identified nature of our
data set, we are unable to completely track out all of the events of
that myocardial infarction. However, I can tell you that among
those 5 patients, 4 did actually contribute to the operative mortal-
ity, so 4 did die. That is, 80% of that small group of patients did die.
Dr Fann. Third, a major conclusion is that OPCAB confers
a lower major complication rate. When assessing the components
of the composite score of major complications, prolonged ventila-
tion comprises the bulk of the difference between the 2 groups in
terms of major complications. This finding is not surprising given
what we know about the effects of CPB. Can you define how long
is prolonged? That is, is it 24 hours, 2 days, or 3 days? Regarding
this complication, the postoperative length of stay between the 2
groups was similar in this study. Thus it is important to know
the definition and significance of prolonged ventilation inasmuch
as it really did not appear to have any clinical sequela in terms
of length of hospital stay and had no impact on overall cost.
Also missing in the preoperative assessment is the incidence of
chronic obstructive pulmonary disease. Is it possible that the
conventional CABG group had a higher incidence of pulmonary
disease, thereby accounting for the difference in the prolonged
ventilation?
DrLaPar. I think you are absolutely right in that when we break
down the composite components of major complications, the high-
est component of that and the biggest contributor was prolonged
ventilation. Prolonged ventilation in this study was defined by
the STS definition as being more than 24 hours of ventilation after
surgery. The influence of that on our composite incidence is clear.
Postoperative ventilation has been shown in the past, especially
within other randomized trials such as the Octopus trial, to be in-
dependently influenced by the use of CPB. Although there are
many factors that may contribute to prolonged ventilation, I still
think that is a valid postoperative complication that does in fact af-
fect patient care. Although in our study we did not demonstrate any
true correlation between the prolonged ventilation and prolonged
intensive care unit or total hospital length of stay, other studies
in the past have shown that prolonged ventilation does in fact con-
tribute to greater resource use and longer patient stays in the hos-
pital. We should definitely try to answer that question more clearly
in the future.
Dr John C. Chen (Honolulu, Hawaii). I want to ask you to ad-
dress the issue of fewer grafts in greater depth. One of the things
that we have been raised to believe in is that surgical mortality
is important, that to have a live patient is perhaps one of the biggest
things we strive for. Our cardiologist colleagues, unfortunately, do
not have the same view at times. They are more interested in num-
ber of grafts that we implant because they believe that the graft
number is important to the patient’s outcome. One of the things
we are looking at is long-term outcome, 5-year survival, in our co-
hort of conventional CABG and OPCAB patients. Are you looking
at that or do you have any plans to look at that to address questions
from our cardiology colleagues?
Dr LaPar. You bring up a very good point. The question of
long-term graft patency and number of grafts and completeness
of revascularization between conventional CABG and OPCABThe Journal of Thoracic and Cand just coronary bypass grafting in general compared with
some of our interventional techniques is very important. In this
study, unfortunately, we were not able to look at any long-term
data because of the de-identified nature of our data set; however,
with regard to the question of graft patency and 5-year long-
term survival within an extreme elderly population such as the oc-
togenarians, I am not quite sure howwell we are going to be able to
answer that in even a small multicenter trial. We need to evaluate
a very large cohort of patients over a very long period of time to
more clearly answer that question, but I certainly am interested
in following up and trying to answer that question.
Dr James Douglas (Bellingham, Wash). Thank you, Dr LaPar.
That was an excellent study, very well presented. For some time I
have had the feeling that in current-day practice of OPCAB sur-
gery, we have been essentially asking the wrong question. I think
your study really highlights that. The question is not whether OP-
CAB is better than conventional CABG, but rather in which pa-
tients is OPCABG better than conventional CABG and vice
versa. Being someone who has been a practitioner of OPCAB
for quite some time, experience has shown me that not everybody
benefits equally. When we try to do randomized studies and in-
clude everybody as if they are equally amenable to it, I think we
make an error in judgment.
The second question that we have not asked appropriately is,
who should be dong OPCAB surgery? It is a different skill set.
Like any of the procedures that we do with a different skill set,
those who are better at the particular skill set will get better results.
Studies have shown that the most improvement with OPCAB sur-
gery has been from those institutions in which the staff has the
most personal experience.
The question I would really like to ask, though, is related to
a different point. I notice that in your paper, as in so many others,
there is a trend toward an improvement in the risk of postoperative
stroke in patients with OPCAB, although it did not reach statistical
significance. One thing that has been very clear from the literature
for many years is that the predominant factor for postoperative
stroke is ascending aortic atherosclerosis. Regardless of whether
you do OPCAB or conventional CABG, if you do not manage
that ascending aorta appropriately you are going to have an in-
creased likelihood of embolization and postoperative stroke.
NowCPB probably has a component to contribute to postoperative
stroke, but it is not the only one and I do not think it is the major
one. Therefore, I do not think it is surprising that the overall inci-
dence was a trend toward it but not absolute. My question revolves
around any evidence that you might have from the VCSQI or
whether the data are available to determine how people manage
the aorta. Would it be feasible to look at the postoperative stroke
outcome in the patients who had specific techniques designed to
prevent perioperative embolization?
Dr LaPar. Thank you very much for that question. Obviously,
patient risk stratification is a very important component in trying to
further define which patients are better served by OPCAB, and
stroke is one of those things that we need to more clearly identify.
Unfortunately, the VCSQI does not have any long-term data or
any sort of data, in fact, that might be able to help us answer how
other practicing surgeons in other institutions are managing the
ascending aorta or in the preoperative, perioperative, or intraoper-
ative setting in making those decisions. I can speak for ourardiovascular Surgery c Volume 141, Number 1 89
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CPB, we use primarily aortic ultrasound intraoperatively to survey
the cannulation sites or just the ascending aorta in general. In cer-
tain patients we are starting to use increasingly preoperative com-
puted tomographic angiography to look at calcification and the
burden of the ascending aorta. Unfortunately, with the VCSQI
we are not able to comment on what some of the other centers
are doing, but that is certainly an important point.
Dr James Brevig (Everett, Wash). I noticed that you had sub-
stantially higher blood use in your conventional CABG cases
than in the OPCAB cases. I also noticed that many of the outcomes
that we have been discussing in terms of mortality, length of stay,
intubation time, and other complications are also associated with90 The Journal of Thoracic and Cardiovascular Surgepacked cell transfusion. What do you think your results would
have looked like if you had a lower transfusion rate in your patients
undergoing conventional CABG?
Dr LaPar. That is a very important point. I personally think that
a major component to the prolonged ventilation occurring in our
conventional CABG pump patients is likely influenced by that in-
creased transfusion requirement and a transient acute lung injury
that may have occurred as a result. That has been a focus of our
basic science laboratory for many years, looking at that effect. If
the transfusion requirements were to be decreased, we probably
would not see as much of an influence on prolonged ventilation,
and it may have helped make our overall morbidity among the
2 patient cohorts much more balanced.ry c January 2011
